Abstract
Arterial stiffness is a powerful predictor of cardiovascular outcome in various patient groups as well as in general population, and can directly accelerate the atherosclerotic process. Arterial stiffness is regulated by numerous factors. Traditionally, mean arterial pressure and structural changes in the components of arterial wall were thought to be main determinants of arterial stiffness, however it is now recognized that arterial stiffness is also regulated by the smooth muscle tone and that endothelium derived mediators, such as NO, contribute to the functional regulation of arterial stiffness. It has also become apparent that inflammation has an important role in the stiffening of the large arteries, possibly via changes in the composition of the arterial wall due to inflammatory cell infiltration or via endothelial dysfunction. Recently, numerous small scale interventional studies have looked into the possibility of using anti-inflammatory and cholesterol- reduction therapies with anti-inflammatory properties as a means to reduce arterial stiffness and therefore cardiovascular risk. Anti-inflammatory therapies, such as corticosteroids and anti-TNF alpha therapy have been shown to reduce arterial stiffness in patients with chronic inflammatory conditions. In addition, statins and other cholesterol-reducing agents have been shown to have beneficial effects on wave reflection and aortic stiffness reduction in several patient groups. This review aims to explore the studies investigating the role of inflammation on arterial stiffening and to review the results from the studies investigating the effect of anti-inflammatory drugs and statins for arterial stiffness reduction and finally, to discuss the potential mechanisms by which these drugs may reduce arterial stiffness.
Keywords: Arterial stiffness, inflammation, anti-inflammatory drugs, statins, cholesterol-reduction
Current Pharmaceutical Design
Title: Anti-Inflammatory Drugs and Statins for Arterial Stiffness Reduction
Volume: 15 Issue: 3
Author(s): Kaisa M. Maki-Petaja and Ian B. Wilkinson
Affiliation:
Keywords: Arterial stiffness, inflammation, anti-inflammatory drugs, statins, cholesterol-reduction
Abstract: Arterial stiffness is a powerful predictor of cardiovascular outcome in various patient groups as well as in general population, and can directly accelerate the atherosclerotic process. Arterial stiffness is regulated by numerous factors. Traditionally, mean arterial pressure and structural changes in the components of arterial wall were thought to be main determinants of arterial stiffness, however it is now recognized that arterial stiffness is also regulated by the smooth muscle tone and that endothelium derived mediators, such as NO, contribute to the functional regulation of arterial stiffness. It has also become apparent that inflammation has an important role in the stiffening of the large arteries, possibly via changes in the composition of the arterial wall due to inflammatory cell infiltration or via endothelial dysfunction. Recently, numerous small scale interventional studies have looked into the possibility of using anti-inflammatory and cholesterol- reduction therapies with anti-inflammatory properties as a means to reduce arterial stiffness and therefore cardiovascular risk. Anti-inflammatory therapies, such as corticosteroids and anti-TNF alpha therapy have been shown to reduce arterial stiffness in patients with chronic inflammatory conditions. In addition, statins and other cholesterol-reducing agents have been shown to have beneficial effects on wave reflection and aortic stiffness reduction in several patient groups. This review aims to explore the studies investigating the role of inflammation on arterial stiffening and to review the results from the studies investigating the effect of anti-inflammatory drugs and statins for arterial stiffness reduction and finally, to discuss the potential mechanisms by which these drugs may reduce arterial stiffness.
Export Options
About this article
Cite this article as:
Maki-Petaja M. Kaisa and Wilkinson B. Ian, Anti-Inflammatory Drugs and Statins for Arterial Stiffness Reduction, Current Pharmaceutical Design 2009; 15 (3) . https://dx.doi.org/10.2174/138161209787354221
DOI https://dx.doi.org/10.2174/138161209787354221 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Oleocanthal, a Natural anti-Inflammatory Compound in Extra Virgin Olive Oil
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Menopause and its Cardiometabolic Consequences: Current Perspectives
Current Vascular Pharmacology Biomarkers in Atrial Fibrillation and Heart Failure
Current Medicinal Chemistry Platelet Turnover in Atherothrombotic Disease
Current Pharmaceutical Design Cross-Talk Between Adipose Tissue Health, Myocardial Metabolism and Vascular Function: The Adipose-Myocardial and Adipose-Vascular Axes
Current Pharmaceutical Design Editorial (Thematic Issue: Induced Pluripotent Stem Cells (iPSCs) in the Gastroenterology and Hepatology: from Basic Research to Clinical Applications)
Current Stem Cell Research & Therapy Experimental Strategies in Autoimmunity: Antagonists of Cytokines and their Receptors, Nanocarriers, Inhibitors of Immunoproteasome, Leukocyte Migration and Protein Kinases
Current Pharmaceutical Design Screening Strategies to Identify New Antibiotics
Current Drug Targets Synthesis and Cytotoxic Activity of 4-Aryl-4H-chromeno[4,3-d] [1,2,3] selenadiazoles
Letters in Drug Design & Discovery Editorial: Bioengineering, Clinical and Therapeutical Trends in Transcatheter Aortic Valve Implantation
Current Pharmaceutical Design University of Kentucky Sanders-Brown Healthy Brain Aging Volunteers: Donor Characteristics, Procedures and Neuropathology
Current Alzheimer Research Dietary Compounds, Epigenetic Modifications and Metabolic Diseases
Current Chemical Biology Pomegranate Extract, A Prooxidant with Antiproliferative and Proapoptotic Activities Preferentially Towards Carcinoma Cells
Anti-Cancer Agents in Medicinal Chemistry Receptor-Based Computational Screening of Compound Databases: The Main Docking-Scoring Engines
Current Protein & Peptide Science Complementary and Alternative Medicine for the Treatment of Insomnia: An Overview of Scientific Evidence from 2008 to 2018
Current Vascular Pharmacology Allograft-Induced Proliferation of Vascular Smooth Muscle Cells: Potential Targets for Treating Transplant Vasculopathy
Current Vascular Pharmacology Long-Chain Omega-3 Fatty Acid Deficiency in Mood Disorders: Rationale for Treatment and Prevention
Current Drug Discovery Technologies SHP-2 Regulates Growth Factor Dependent Vascular Signalling and Function
Mini-Reviews in Medicinal Chemistry The Application of Rational Design on Phospholipase A2 Inhibitors
Current Medicinal Chemistry Oxidative Stress and Mitochondrial Impairment After Treatment with Anti-HIV Drugs: Clinical Implications
Current Pharmaceutical Design